Promising therapeutic efficacy of kolaviron against prenatal valproate-induced autism spectrum disorder

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 31

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-8_006

تاریخ نمایه سازی: 14 مرداد 1405

چکیده مقاله:

Objective(s): Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition marked by impairments in social communication, language, and behavior. Prenatal exposure to valproic acid (VPA) contributes to its pathogenesis. kolaviron (KV), a polyphenolic extract from Garcinia kola, has potent antioxidant and anti-inflammatory properties, offering neuroprotective potential in ASD models. Our study aimed to evaluate whether KV could improve the VPA-induced autism model through targeting serotonergic system, mitochondrial dysregulation, oxidative stress, and inflammation.Materials and Methods: Pregnant Wistar rats received a single intraperitoneal dose of VPA (۶۰۰ mg/kg) on gestational day ۱۲.۵ to induce autism-like features in offspring. Male pups were weaned on postnatal day (PND) ۲۱ and randomly assigned to receive KV (۵۰ or ۱۰۰ mg/kg, oral), or saline until PND ۴۹. Behavioral tests were finally conducted and brain tissue was collected for analysis of hippocampal oxidative stress, mitochondrial dysfunction, serotonin transporter (۵-HTT), serotonin receptor ۷ (۵-HTR۷), tumor necrosis factor α (TNF), and interleukin ۶ (IL-۶) levels. Immunohistochemical staining for glial fibrillary acidic protein (GFAP) was also performed to assess astrocytic reaction.Results: KV-treated VPA-exposed rats showed significant improvements in social interaction and with lower repetitive behavior. Biochemically, KV decreased malondialdehyde (MDA), IL-۶ and TNFα levels, improved catalase activity and mitochondrial membrane potential (MMP), and modulated serotonergic markers (۵-HTT and ۵-HTR۷). Histologically, KV also attenuated hippocampal GFAP immunoreactivity (IRA). Conclusion: KV showed its promising potential as a complementary therapeutic agent in ASD murine model. Further studies are still warranted to clarify its further mechanisms and clinical relevance.

نویسندگان

Vahid Khodashenas

Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Tourandokht Baluchnejadmojarad

Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Mitra Farbin

Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Ali Khodabakhshi Korelaei

Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Soraya Mehrabi

Cellular and Molecular Research Center, Iran university of Medical Sciences, Tehran, Iran

Mehrdad Roghani

Neurophysiology Research Center, Shahed University, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Mehra S, Ul Ahsan A, Seth E, Chopra M. Critical ...
  • Gouda B, Sinha SN, Sangaraju R, Huynh T, Patangay S, ...
  • Kuźniar-Pałka A. The role of oxidative stress in autism spectrum ...
  • Petruzzelli MG, Matera E, Margari L, Marzulli L, Gabellone A, ...
  • Afshari M, Gharibzadeh S, Pouretemad H, Roghani M. Promising therapeutic ...
  • Ukezono M, Kasahara Y, Yoshida C, Murakami Y, Okada T, ...
  • Al-Dossari AM, Al-Harbi LN, Al-Otaibi NM, Almubarak A, Almnaizel AT, ...
  • Kuo HY, Liu FC. Pathophysiological studies of monoaminergic neurotransmission systems ...
  • Farrag EAE, Askar MH, Abdallah Z, Mahmoud SM, Abdulhai EA, ...
  • Nicolini C, Fahnestock M. The valproic acid-induced rodent model of ...
  • Ayepola OR, Cerf ME, Brooks NL, Oguntibeju OO. kolaviron, a ...
  • Farombi EO, Awogbindin IO, Farombi TH, Oladele JO, Izomoh ER, ...
  • Nazari-Serenjeh M, Baluchnejadmojarad T, Hatami-Morassa M, Fahanik-Babaei J, Mehrabi S, ...
  • Oyovwi MO, Ben-Azu B, Edesiri TP, Victor E, Rotu RA, ...
  • Omotoso GO, Arietarhire LO, Ukwubile II, Gbadamosi IT. The protective ...
  • Omotoso GO, Mutholib NY, Abdulsalam FA , Bature AI. Kolaviron ...
  • Usui N, Kobayashi H, Shimada S. Neuroinflammation and oxidative stress ...
  • Muller CL, Anacker AMJ, Veenstra-VanderWeele J. The serotonin system in ...
  • Afshari M, Gharibzadeh S, Pouretemad H, Roghani M. Reversing valproic ...
  • Zahedi E, Sadr SS, Sanaeierad A, Roghani M. Chronic acetyl-L-carnitine ...
  • Feriyani F, Maulanza H, Lubis RR, Balqis U, Darmawi D. ...
  • Ghalami J, Baluchnejad Mojarad T, Mansouri M, Khamse S, Roghani ...
  • Teixeira FC, Gutierres JM, Soares MSP, da Siveira de Mattos ...
  • Ding J, Yu HL, Ma WW, Xi YD, Zhao X, ...
  • Pourmohammadi S, Roghani M, Kiasalari Z, Khalili M. Paeonol ameliorates ...
  • Olatoye FJ, Akindele AJ, Awodele O. The role of kolaviron, ...
  • Tauchen J, Frankova A, Manourova A, Valterova I, Lojka B ...
  • Omotoso GO, Mutholib NY, Abdulsalam FA, Bature AI. Kolaviron protects ...
  • Chen S, Huang L, Liu G, Kang J, Qian Q, ...
  • Omotoso GO, Arietarhire LO, Ukwubile, II, Gbadamosi IT. The protective ...
  • Rahdar M, Davoudi S, Dehghan S, Javan M, Hosseinmardi N, ...
  • Bristot Silvestrin R, Bambini-Junior V, Galland F, Daniele Bobermim L, ...
  • Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. ...
  • Laurence JA, Fatemi SH. Glial fibrillary acidic protein is elevated ...
  • نمایش کامل مراجع